Your browser doesn't support javascript.
loading
Thorax radiotherapy using 18F-positron emission tomography/computed tomography-guided precision radiotherapy is a prognostic factor for survival in patients with extracranial oligometastatic non-small cell lung cancer:A two-center propensity score-matched analysis.
Liu, Cheng-Sen; Song, Ying-Qiu; Wang, Run-Ze; Wang, Zheng; He, Rong; Xu, Ke; Wang, Chen-Yu; Wu, Yu; Wang, Ye; Zhang, Xiao-Fang; Li, Guang; Wang, Tian-Lu.
Afiliación
  • Liu CS; Department of Radiotherapy, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, Liaoning, China.
  • Song YQ; Department of Radiotherapy, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, Liaoning, China.
  • Wang RZ; Department of Radiotherapy, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, Liaoning, China.
  • Wang Z; Department of Thoracic Surgery, Liaoning Cancer Hospital and Institute, Shenyang, Liaoning, China.
  • He R; Department of Thoracic Surgery, Liaoning Cancer Hospital and Institute, Shenyang, Liaoning, China.
  • Xu K; Department of Thoracic Surgery, Liaoning Cancer Hospital and Institute, Shenyang, Liaoning, China.
  • Wang CY; Department of Information Management, Liaoning Cancer Hospital and Institute, Shenyang, Liaoning, China.
  • Wu Y; Department of Radiotherapy, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, Liaoning, China.
  • Wang Y; Department of Radiotherapy, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, Liaoning, China.
  • Zhang XF; Department of Radiotherapy, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, Liaoning, China.
  • Li G; Department of Radiotherapy, The First Hospital of China Medical University, Shenyang, Liaoning, China.
  • Wang TL; Department of Radiotherapy, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, Liaoning, China.
Front Oncol ; 12: 991378, 2022.
Article en En | MEDLINE | ID: mdl-36353556
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza